We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MONDE:PSEMonde Nissin Corp. Analysis

Data as of 2026-03-17 - not real-time

$58.60

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Mondelez International trades near its 20‑day simple moving average, with the 50‑day SMA just below the current price and the 200‑day SMA still providing resistance, indicating a neutral technical stance. The MACD has turned bearish while the RSI hovers around the midpoint, suggesting limited upside momentum in the near term. Fundamentals show solid revenue growth and healthy operating cash flow, but a high debt‑to‑equity ratio and a payout ratio above 100% raise concerns about dividend sustainability. The DCF fair‑value estimate sits well below the market price, implying the stock is currently overvalued despite an attractive dividend yield.
Investor sentiment is buoyant, reflected by an “Extreme Greed” reading on the fear‑greed index, yet the stock’s volatility over the past month exceeds 30% and its beta remains low, underscoring a defensive profile with heightened price swings. The upcoming dividend declaration and the company’s strategic push in developed markets could provide short‑term catalysts, but the overvaluation and modest growth outlook suggest a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram
  • Price near short‑term support
  • High dividend yield but unsustainable payout

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Stable revenue growth and strong cash flow generation
  • Elevated debt level limiting financial flexibility
  • Strategic initiatives in developed markets expected to drive modest expansion

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Defensive consumer‑staples positioning with resilient demand
  • Potential for dividend policy adjustment to improve sustainability
  • Long‑term upside from brand strength and global distribution network

Key Metrics & Analysis

Financial Health

Revenue Growth9.30%
Profit Margin6.36%
P/E Ratio31.0
ROE9.33%
ROA3.24%
Debt/Equity84.85
P/B Ratio2.9
Op. Cash Flow$4.5B
Free Cash Flow$3.6B

Technical Analysis

TrendNeutral
RSI51.9
Support$54.31
Resistance$61.76
MA 20$58.51
MA 50$58.15
MA 200$60.93
MACDBearish
VolumeStable
Fear & Greed Index81.2

Valuation

Fair Value$40.61
Target Price$67.13
Upside/Downside14.55%
GradeOvervalued
TypeBlend
Dividend Yield3.50%

Risk Assessment

Beta0.12
Volatility30.32%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.